Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Dose-Finding and Dose-Expansion Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

NCT07229313 is registered in ClinicalTrials.gov with Kivu Bioscience Inc. as lead sponsor.

NCT NCT07229313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07229313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Dose-Finding and Dose-Expansion Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Lead sponsor
Kivu Bioscience Inc.
Phase
Phase 1
Overall status
Recruiting
Start date
November 13, 2025
Completion date
March 31, 2030
Enrollment
76 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

advance solid tumors